Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EBV
|
|||
| Former ID |
DIB008697
|
|||
| Drug Name |
JNS-001
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 3 | [1] | |
| Company |
Janssen Pharmaceutical KK
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01323192) An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.